Prostatic Neoplasms Terminated Phase 2 Trials for L-Arginine (DB00125)

Also known as: Neoplasm,Prostatic / Neoplasms, Prostatic / Prostatic Neoplasm

IndicationStatusPhase
DBCOND0028225 (Prostatic Neoplasms)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01995058Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate CancerTreatment